Yes, stupidly was thinking 11% was better and must
Post# of 148165
Had sent you a PM when I saw your post with the correct numbers.
Thanks for calculating the numbers the right way.
It sounds like you are assuming the 24% improvement is a relative risk reduction, which is probably correct.
Assuming so and taking the "better" possibility, with placebo mortality say 57.9% (11/19) and leronlimab lowering it to 44.2% (19/43), and that those numbers bore out in a larger trial, what is the number needed with those percentages to get a statistically significant finding?